Ulcerative colitis, or UC, is one of those conditions that can quietly take over a person’s life long before other people understand how serious it is. It is not just stomach pain. It can mean bleeding, cramping, urgency, fatigue, poor sleep, missed plans, and whole days built around where the nearest bathroom is.1 And in the United States, this is affecting far more people than many realize. Millions of people are living with inflammatory bowel disease (IBD), the larger group of conditions that includes UC, and the burden is still growing.1
But starting a new UC treatment poses another challenge . New research from the Crohn’s & Colitis Foundation reveals that the way people experience Inflammatory Bowel Disease (IBD) often depends on their background and financial situation.2 For example, Black seniors with IBD are significantly more likely to visit the emergency room than White patients in the same age group.2 Meanwhile, Asian and Hispanic working-age adults are less likely to receive the most advanced medical treatments compared to their White peers.2
In other words, this is not only a disease story. It is also a care access story, a treatment equity story, and a quality-of-life story.
That is why this article matters for the NOWINCLUDED community. Starting a new UC treatment is not just about picking up a prescription and hoping for the best. It is about understanding what this disease is doing in the body, what your medication is supposed to do, and what questions help you protect your health from the start. We are going to break all of that down clearly, so readers can move into treatment feeling informed, prepared, and less alone.
What Ulcerative Colitis Is, In Plain Language
Ulcerative colitis, or UC, is a form of inflammatory bowel disease.1 It causes chronic inflammation and sores, also called ulcers, in the lining of the large intestine, which includes the colon and rectum.1 Unlike Crohn’s disease, which can affect different parts of the digestive tract and deeper layers of tissue, ulcerative colitis affects the colon and rectum and involves the inner lining.1
In plain language, UC means the immune system is driving inflammation in the colon, and that inflammation can lead to symptoms like diarrhea, urgency, rectal bleeding, abdominal pain, fatigue, and weight loss.1 Some people with UC have a milder disease, while others deal with flares that are severe, disruptive, and sometimes dangerous enough to require hospitalization.1
How Ulcerative Colitis Can Affect Daily Life
Ulcerative colitis is more than a bathroom problem. It can shape how someone eats, sleeps, works, travels, and plans their day.3 A person may need to know where every bathroom is before leaving the house. They may feel anxious about flares, exhausted from blood loss or poor sleep, or worn down by ongoing urgency and cramping. Over time, that can affect mental health, work attendance, and basic quality of life.3
That is one reason treatment decisions matter so much. The right medication plan is not only about healing inflammation on a scope. It is also about making daily life more livable and lowering the risk of complications like hospitalization, steroid dependence, or surgery.3
Common UC Symptoms And Why Treatment May Need To Change
Common UC symptoms include diarrhea, blood in the stool, abdominal pain, urgency, tenesmus (the feeling that you still need to have a bowel movement), fatigue, and unintended weight loss.1
Some people also develop anemia or signs of malnutrition when the disease is active for a long time.1
Treatment may need to change when symptoms are not improving, when a person is having repeated flares, when side effects become too hard to tolerate, or when inflammation is still active even if symptoms are somewhat better.1
That last part matters. Sometimes symptoms improve before the colon is truly healing, which is one reason follow-up care and treatment adjustments are common in UC.
The Main Types Of UC Treatments
UC treatment usually falls into a few major medication categories:
1) Aminosalicylates: The Most Common Starting Point
Aminosalicylates, often called 5-ASAs, include medicines such as mesalamine, balsalazide, olsalazine, and sulfasalazine.4
These medications are often used to treat mild to moderate UC and to help maintain remission. They can be taken by mouth or, in some cases, rectally, which can be especially useful when inflammation is lower in the colon or rectum.4
These medicines work by reducing inflammation in the lining of the intestine.4 They are often appealing because they do not suppress the immune system the way some other UC drugs do.
Common side effects can include headache, nausea, abdominal discomfort, or diarrhea.4 Some people tolerate one 5-ASA better than another, which is one reason medication adjustments within the same class are sometimes possible.
2) Corticosteroids: Useful, But Usually Not For Long-Term Use
Corticosteroids, often just called steroids, are used to get active inflammation under control when disease is moderate to severe or when 5-ASAs are not enough.4 Examples include prednisone, methylprednisolone, and budesonide.4
They can work quickly, which is why they are often used during a flare.4 The important thing to know is that steroids are usually not meant for long-term maintenance.
Common side effects can include mood changes, sleep problems, increased blood sugar, weight gain, bone loss, infection risk, and other complications.4
3) Immunomodulators: Slower, But Sometimes Important For Maintenance
Immunomodulators are medicines that adjust or suppress parts of the immune system to reduce ongoing inflammation.4 Common examples include azathioprine and mercaptopurine.4
These are often used more for maintenance than for rapid symptom relief because they usually take longer to work.4
Because these medications affect the immune system, they can come with infection risk and may require regular lab monitoring.4 Depending on the drug, doctors may also watch liver tests, blood counts, and other markers closely.4
These medicines are not right for everyone, but they are still part of the UC treatment toolbox, especially in certain maintenance strategies.
4) Biologics: Targeted Immune Therapy For Moderate To Severe UC
Biologics are medicines that target specific parts of the immune system involved in inflammation.4 Common UC biologics include infliximab, adalimumab, golimumab, vedolizumab, ustekinumab, mirikizumab, guselkumab, and risankizumab, though some are newer additions in evolving guidelines and approvals.4
They may be given by infusion or injection, depending on the medication.4 These medicines can be very effective, but patients should know the tradeoff: because they change immune system signaling, they can increase infection risk.4
Common side effects may include headache, fatigue, chills, fever, rash, or redness and pain at the injection or infusion site.4 In rare cases, allergic or infusion reactions can happen.4
5) Targeted Small Molecules: Oral Options With Important Safety Questions
Targeted small-molecule therapies are newer oral medications that work on specific immune pathways.4 In UC, this category includes JAK inhibitors such as tofacitinib and upadacitinib, and S1P receptor modulators such as ozanimod and etrasimod.4
These options can be appealing because they are pills rather than injections or infusions, but they also come with important safety discussions.4 Depending on the medication, concerns may include infection risk, blood clots, cholesterol changes, liver effects, heart-related warnings, or monitoring needs.4
This is exactly why patients should not start these drugs with only a brand name and a quick summary. They need the fuller conversation.
|
Category
|
Common Names
|
How it’s Taken
|
Best For...
|
|---|---|---|---|
|
Aminosalicylates (5-ASAs) |
Mesalamine, Sulfasalazine |
Oral Pill / Rectal |
Mild to Moderate / Maintenance |
|
Corticosteroids |
Prednisone, Budesonide |
Oral / IV |
Short-term "Flare" Control |
|
Biologics |
Humira, Remicade, Entyvio |
Injection / Infusion |
Moderate to Severe / Long-term |
|
Small Molecules |
Xeljanz, Rinvoq, Zeposia |
Daily Pill |
Moderate to Severe / "Pill" preference |
How Doctors Decide Which UC Treatment To Use
The choice depends on more than symptoms alone. Typically, doctors look at:
- how severe the disease is
- how much of the colon is involved
- whether the patient has been hospitalized
- whether steroids have already been needed
- whether the patient has already tried and failed another therapy
- what other medical conditions are in the picture
That is why one person may start with mesalamine while another is offered a biologic or a targeted oral therapy much earlier. Treatment choice is also shaped by insurance coverage, infusion access, pregnancy plans, infection risk, lab monitoring, and what side effects feel acceptable to the person taking the medication.4
What To Ask Before Starting A New UC Treatment
Starting a new treatment for UC is often a mix of relief and uncertainty; while you’re eager for a path toward remission, the transition to a new regimen can feel overwhelming.
To move forward with confidence, it is essential to shift from being a passive recipient of care to an active partner in your treatment plan. By asking the right questions upfront, you can align your expectations with reality and ensure that you and your medical team are working toward the same goals.
The following steps outline the critical conversations you should have with your gastroenterologist to ensure your next phase of treatment is as clear and effective as possible.
Step 1: Start with the basic purpose of the medication.
Ask whether this drug is meant to calm a flare quickly, maintain remission over time, or do both.
That one question can immediately clarify whether you are being given a short-term bridge or a long-term plan. This matters especially with steroids, because many patients feel better on them quickly but are not meant to stay on them long term.
Step 2: Ask how long it usually takes to work.
Some treatments act much faster than others. If a medication takes weeks or months to show its full effect, you deserve to know that before assuming it is failing too soon.
Step 3: Ask what side effects are most common and which ones are considered urgent.
A patient starting mesalamine may be listening for headache or stomach upset. A patient starting a biologic or JAK inhibitor may need a much more detailed conversation about infection risk, infusion reactions, or lab monitoring.
Step 4: Ask what testing is needed before and during treatment.
Some medications require bloodwork, tuberculosis testing, hepatitis screening, liver monitoring, or follow-up labs to make sure the medication is safe and working as intended.
Step 5: Ask what the next step will be if this treatment does not work well enough.
That question matters because it turns treatment into a plan rather than a gamble. It also helps patients understand that lack of response is something to manage, not a personal failure.
Step 6: Ask how the medication fits your real life.
Does it require infusions? Injections? Daily pills? Frequent labs? Refrigeration? Prior authorization? Time off work? These practical details affect adherence more than people sometimes admit.
Self-Advocacy Language For Readers
If you are about to start a new UC treatment, and aren’t sure what to say, try using these words:
- “Can you explain why you’re choosing this treatment for my ulcerative colitis instead of the other options?”
- “Is this medication meant to calm my flare quickly, keep me in remission, or both?”
- “What side effects are common, and which ones should make me call right away?”
- “What testing do I need before I start, and what monitoring will happen while I’m on it?”
- “If this treatment doesn’t work well enough, what would the next step be?”
- “I want to make sure this plan fits my real life. What should I know about infusions, injections, lab work, insurance approval, and cost?”
Before Starting a New UC Treatment, Ask The NOWINCLUDED Community
Starting a new UC treatment can feel intimidating, but it should not feel mysterious. The more clearly people understand what the medication is meant to do, what side effects matter, and what questions to ask, the better prepared they are to move through treatment with confidence instead of guesswork.
Inside the NOWINCLUDED app, you can find trusted, clear health education that helps connect diagnosis, treatment, and real-life decision-making.
Use it to prepare for your next GI visit, strengthen your questions, and make sure your treatment plan makes sense not only on paper, but in your actual life.
References:
- The Crohn’s & Colitis Foundation. (2026). Overview of Ulcerative Colitis. Retrieved from The Crohn’s & Colitis Foundation: https://www.crohnscolitisfoundation.org/patientsandcaregivers/what-is-ulcerative-colitis/overview
- The Crohn’s & Colitis Foundation. (2025, March 28). Study Reveals Stark Racial Disparities in IBD Care Across the United States. Retrieved from The Crohn’s & Colitis Foundation: https://www.crohnscolitisfoundation.org/study-reveals-stark-racial-disparities-ibd-care-across-the-united-states
- Armuzzi, A., & Liguori, G. (2021). Quality of life in patients with moderate to severe ulcerative colitis and the impact of treatment: A narrative review. Digestive and Liver Disease. doi:https://doi.org/10.1016/j.dld.2021.03.002
- NIH. (2020, September ). Treatment for Ulcerative Colitis. Retrieved from NIH: National Institute of Diabetes and Digestive and Kidney Diseases: https://www.niddk.nih.gov/health-information/digestive-diseases/ulcerative-colitis/treatment
